Literature DB >> 26152940

Photodocumentation of Allergic Severity under Conjunctival Provocation.

Anatoli Astvatsatourov1, Yann Reydelet1, Ralph Mösges1.   

Abstract

The aim of this work was to evaluate conjunctival redness as an objective allergy symptom during the conjunctival provocation test (CPT). The CPT is an instillation of ophthalmic solution containing an allergen into the ocular mucosa. Allergic severity using the CPT was evaluated in the multicenter, randomized, controlled, double-blind, dose-finding study of 159 patients with birch pollen allergy where the mucosal sensitivity of the eye was assessed based on subjective and objective symptoms such as itching and redness, respectively. High-resolution digital photos were taken, arranged in image matrices, and analyzed by an external central observer to assess conjunctival redness. The photodocumentation method described here was successfully applied in a dose-finding study using the CPT. The evaluations of allergic severity carried out by an external observer agreed with the investigators' assessments.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26152940

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  3 in total

1.  Liposomal Eye Spray Is as Effective as Antihistamine Eye Drops in Patients with Allergic Rhinoconjunctivitis Induced by Conjunctival Provocation Testing.

Authors:  Anne-Nele Grzella; Sabine Schleicher; Kija Shah-Hosseini; Anatoli Astvatsatourov; Esther Raskopf; Silke Allekotte; Ralph Mösges
Journal:  Int Arch Allergy Immunol       Date:  2019-03-25       Impact factor: 2.749

Review 2.  Clinical trials in allergen immunotherapy: current concepts and future needs.

Authors:  O Pfaar; M Alvaro; V Cardona; E Hamelmann; R Mösges; J Kleine-Tebbe
Journal:  Allergy       Date:  2018-04-16       Impact factor: 13.146

3.  A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.

Authors:  R Mösges; E M Kasche; E Raskopf; J Singh; L Sohlich; A Astvatsatourov; K Shah-Hosseini; S Pirotton; L Haazen; S R Durham; T Legon; G Zadoyan; M H Shamji
Journal:  Allergy       Date:  2017-12-22       Impact factor: 13.146

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.